Waters Application Note
Michael S. Young, Waters Corp., Milford, Massachusetts, USA.
A recent poll indicated that millions of consumers were "very" concerned that their public water supplies may be contaminated with trace amounts of pharmaceuticals.1
These compounds enter the water supply in a variety of ways. Drug residues are introduced to wastewater from hospitals and pharmaceutical manufacturers, from consumer disposal of unused drugs and from human waste. Because water and waste treatment plants in the US do not typically remove pharmaceuticals, these compounds may ultimately pass into the drinking water supply.2
Some utilities have begun to test for these compounds using Oasis HLB cartridges.3 This application note describes the UPLC–MS determination of pharmaceutical compounds using Oasis HLB sorbent in a 47 mm SPE disc format. The Oasis HLB disk provides a suitable alternative that can be used for larger sample sizes and for dirtier samples with sufficient particulate matter to hinder cartridge SPE sampling.
This application note discusses SPE methodology for determination of most basic, acidic and neutral drugs.
The disc is first conditioned with methanol (10 mL) and water (10 mL). Then the 1 L sample is loaded followed by a 10 mL water wash. The sample is eluted with methanol (5 mL), 2% ammonia/methanol (12 mL) and 50:50 acetone/methanol (6 mL). The combined eluents are evaporated and reconstituted prior to UPLC–MS analysis.
All analyses were performed using an ACQUITY UPLC BEH C18 column, 2.1 × 100 mm, 1.7 μm.
The mass spectrometer was a Waters Quattro Premier XE operated in MRM mode using positive electrospray for bases and neutrals and in negative electrospray for acids.
The Oasis HLB disc performs well for the isolation and enrichment of many classes of pharmaceutical and related compounds from water samples. Figure 1 shows UPLC–MS chromatograms obtained for some basic and acidic pharmaceuticals determined in a fortified river water sample. The results were comparable to results obtained using EPA Method 1694.3 Significant advantages of the HLB disc format include the ability to process larger and dirtier water samples than practical using a cartridge format. In addition, the disc format can be used for the extraction of water sample containing a significant amount of particulate matter, which is not possible using a cartridge.
Figure 1: Some group 1 (base/neutrals) and group 3 (acids) compounds extracted at acid pH from river water with spike levels noted.
For the complete application note, visit www.waters.com/30363
1. J. Donn, M. Mendoza and J. Pritchard, "AP Probe Finds Drugs in Drinking Water", Associated Press (various outlets) (9 March 2008).
2. D.M. Bauman, Drugs in the Water, Water Technology, 22–24 (May 2008).
3. EPA Method 1694: Pharmaceuticals and Personal Care Products in Water, Soil, Sediment, and Biosolids by HPLC–MS–MS, US Environmental Protection Agency Office of Water, EPA-821-R-08-002 (December 2007).
© 2009 Waters Corporation. Waters, The Science of What's Possible, Oasis, ACQUITY UPLC, UPLC, and Quattro Premier are trademarks of Waters Corporation.
Waters Corporation
34 Maple Street, Milford, Massachusetts 01757, USA
tel. +1 508 478 2000 fax +1 508 482 3605
Website: www.waters.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Katelynn Perrault Uptmor Receives the 2025 LCGC Emerging Leader in Chromatography Award
Published: November 13th 2024 | Updated: November 13th 2024November 13, 2024 – LCGC International magazine has named Katelynn A. Perrault Uptmor, Assistant Professor of Chemistry at the College of William & Mary, the recipient of the 2025 Emerging Leader in Chromatography Award. This accolade, which highlights exceptional achievements by early-career scientists, celebrates Perrault Uptmor’s pioneering work in chromatography, particularly in the fields of forensic science, odor analysis, and complex volatile organic compounds (VOCs) research.